Table 6 Pathogens isolated from new tympanic membrane perforations
Perforation pathogen category | Vaccinated N = 97 (194 ears) | Comparison N = 51 (102 ears) |
|---|---|---|
New perforations | 73 (38% of ears) | 72 (71% of ears) |
New perforation discharge specimen collected | 59/73 (81% new perforations) | 44/72 (61% new perforations) |
Positive discharge specimens* | 32/59 (54% specimens) | 25/44 (57% specimens) |
S. pneumoniae | 19/32 (59% positive specimens) | 16/25 (64% positive specimens) |
   All vaccine-types | 7 (22%) | 8 (32%) |
   Serotype 6B | 2 (3%) | 5 (20%) |
   All vaccine-related types | 6 (19%) | 2 (8%) |
   Serotype 19A | 4 (13%) | 2 (8%) |
   All non-vaccine types | 9 (28%) | 6 (24%) |
   Serotype 16F | 4 (13%) | 2 (8%) |
H. influenzae | 28 (88%) | 21 (84%) |
M. catarrhalis | 0 (0%) | 2 (8%) |
S. pneumoniae & H. influenzae †| 15 (47%) | 12 (48%) |